Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLOV NYSE:HIMS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$4.44-5.1%$4.20$1.58▼$5.59$2.46B2.416.83 million shs6.00 million shsHIMSHims & Hers Health$34.45-2.8%$29.37$13.74▼$70.43$8.21B2.3516.18 million shs11.83 million shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments-5.13%-15.59%-9.20%+130.05%+40.06%HIMSHims & Hers Health-3.05%-6.26%+23.74%+77.10%-32.64%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$4.44-5.1%$4.20$1.58▼$5.59$2.46B2.416.83 million shs6.00 million shsHIMSHims & Hers Health$34.45-2.8%$29.37$13.74▼$70.43$8.21B2.3516.18 million shs11.83 million shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments-5.13%-15.59%-9.20%+130.05%+40.06%HIMSHims & Hers Health-3.05%-6.26%+23.74%+77.10%-32.64%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLOVClover Health Investments 2.00Hold$3.82-14.04% DownsideHIMSHims & Hers Health 2.13Hold$30.70-10.88% DownsideCurrent Analyst Ratings BreakdownLatest CLOV and HIMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$36.00 ➝ $37.007/1/2026HIMSHims & Hers Health Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$32.00 ➝ $40.007/1/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$25.00 ➝ $36.006/24/2026CLOVClover Health Investments Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/17/2026HIMSHims & Hers Health BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$29.00 ➝ $39.006/11/2026CLOVClover Health Investments UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$2.75 ➝ $4.756/8/2026HIMSHims & Hers Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell6/4/2026CLOVClover Health Investments Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$3.20 ➝ $4.205/26/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$28.00 ➝ $25.005/22/2026HIMSHims & Hers Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$23.005/22/2026HIMSHims & Hers Health Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$18.00 ➝ $23.00(Data available from 7/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLOVClover Health Investments$1.92B1.22N/AN/A$0.59 per share7.53HIMSHims & Hers Health$2.35B3.40$0.81 per share42.36$2.38 per share14.47Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLOVClover Health Investments-$85.55M-$0.12N/AN/AN/A-2.58%-16.52%-9.28%8/4/2026 (Estimated)HIMSHims & Hers Health$128.37M-$0.09N/A66.2599.77-0.56%6.10%1.52%8/10/2026 (Estimated)Latest CLOV and HIMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026CLOVClover Health Investments$0.05N/AN/AN/A$728.27 millionN/A5/11/2026Q1 2026HIMSHims & Hers Health$0.04-$0.40-$0.44-$0.40$616.84 million$608.10 million5/6/2026Q1 2026CLOVClover Health Investments$0.07$0.05-$0.02$0.05$714.89 million$749.19 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCLOVClover Health InvestmentsN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLOVClover Health InvestmentsN/A1.331.33HIMSHims & Hers Health2.181.691.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLOVClover Health Investments19.77%HIMSHims & Hers Health63.52%Insider OwnershipCompanyInsider OwnershipCLOVClover Health Investments23.51%HIMSHims & Hers Health11.76%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLOVClover Health Investments680526.68 million402.86 millionOptionableHIMSHims & Hers Health2,442231.46 million204.24 millionOptionableCLOV and HIMS HeadlinesRecent News About These CompaniesJanney Montgomery Scott LLC Acquires 40,023 Shares of Hims & Hers Health, Inc. $HIMS56 minutes ago | marketbeat.comBank of America Increases Hims & Hers Health (NYSE:HIMS) Price Target to $37.00July 9 at 8:11 AM | marketbeat.comAs Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner...July 8 at 9:45 AM | marketbeat.comHims & Hers Health: The Market Still Doesn't Get ItJuly 8 at 9:00 AM | seekingalpha.comHims & Hers Health (NYSE:HIMS) CFO Sells 7,163 SharesJuly 8 at 5:37 AM | insidertrades.comHere's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader MarketJuly 7, 2026 | zacks.comOluyemi Okupe Sells 7,163 Shares of Hims & Hers Health (NYSE:HIMS) StockJuly 7, 2026 | marketbeat.comHims & Hers (HIMS) Stock May Be Undervalued After FDA Peptide QuestionsJuly 7, 2026 | finance.yahoo.comHims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?July 6, 2026 | fool.comHIMS Stock Rises Overnight: CEO Shrugs Off Wild Swings, Bets On ‘Gold Standard’ Of Healthcare Over Next DecadeJuly 6, 2026 | stocktwits.comSLouisiana State Employees Retirement System Acquires New Holdings in Hims & Hers Health, Inc. $HIMSJuly 4, 2026 | marketbeat.comHIMS Breakout Signals Structural Business TransformationJuly 3, 2026 | seekingalpha.comHims & Hers stock surges as analysts lift price targetsJuly 2, 2026 | msn.comAmplify Online Retail ETF Rides a Summer Surge in PerformanceJuly 2, 2026 | etftrends.comESector Update: Healthcare Stocks Higher Late AfternoonJuly 1, 2026 | finance.yahoo.comFour stock-moving events to watch as FDA revives AdComsJuly 1, 2026 | seekingalpha.comHims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should KnowJuly 1, 2026 | finance.yahoo.comHims & Hers stock jumps as Canaccord lifts target price ahead of FDA reviewJuly 1, 2026 | invezz.comIHims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should KnowJuly 1, 2026 | zacks.comHIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’July 1, 2026 | stocktwits.comSHims & Hers Health (NYSE:HIMS) Stock Price Expected to Rise, Bank of America Analyst SaysJuly 1, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026SpaceX Rings the Bell and Shatters Every RecordBy Jeffrey Neal Johnson | June 12, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026The Oil Trade May Not Be Over: 3 Energy Stocks to WatchBy Thomas Hughes | June 21, 2026As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the WinnerBy Jessica Mitacek | July 6, 2026CLOV and HIMS Company DescriptionsClover Health Investments NASDAQ:CLOV$4.44 -0.24 (-5.13%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$4.44 +0.00 (+0.11%) As of 07/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Hims & Hers Health NYSE:HIMS$34.45 -1.00 (-2.82%) Closing price 07/10/2026 03:59 PM EasternExtended Trading$34.23 -0.22 (-0.65%) As of 07/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/06 - 07/10 Why WD-40 Is Proving Great Businesses Never Go Out of Style Rocket Lab’s Stock Drop Comes With a Bullish Twist Pushing the Edge: Super Micro Computer Reboots the AI Landscape Micron's $250 Billion Bet Could Reshape the AI Memory Race AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
